Dallas is focusing on new and advanced treatments, like those that use cells or genes. They are also looking at how biology ...
TSRA-196 is a potential one-time treatment to precisely correct the genetic mutation underlying AATD, with Investigational New Drug filing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback